CDKN2A and neoplasm: In mice with mutant Kras and deletion of Cdkn2a in lung epithelial cells, lung tumors develop with activation of ERK, RHOA, and FAK, and subsequent deletion or pharmacologic inhibition of FAK resulted in tumor regression (33).